Atrovent®

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

ColdPulmonary Disease, Chronic Obstructive

Phase 4

Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy

CompletedNCT02238210

Boehringer IngelheimCold

Start: 2002-12-31Updated: 2014-09-12

Unknown Phase

Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease

CompletedNCT02236715

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1999-09-30Updated: 2014-09-11

Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02238184

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2001-01-31Updated: 2014-09-12